John P. Furey's most recent trade in Vaxcyte Inc was a trade of 15,372 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaxcyte Inc | John P. Furey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 15,372 | 15,372 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | John P. Furey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 3,041 | 3,041 | - | 0 | Common Stock | |
| Vaxcyte Inc | John P. Furey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2024 | 16,760 | 16,760 | - | - | Stock Option (right to buy) | |
| Adaptimmune Therapeutics P... | John P. Furey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 660,000 | 660,000 | - | - | Option to purchase Ordinary Shares |